Aridis to Participate in Key Opinion Leader Discussion on Immunotherapy for Infectious Diseases
November 22, 2022 09:10 ET
|
Aridis Pharmaceuticals, Inc.
The Company’s superiority Phase 3 ‘ASAP-1' study of AR-301 monoclonal antibody in S. aureus pneumonia and the pending data readout will be a focus of the KOL event Los Gatos, Calif., Nov. 22, 2022 ...
Point-of-Care Diagnostics Market Worth $82.74 Billion by 2029 - Exclusive Report by Meticulous Research®
November 22, 2022 09:00 ET
|
Meticulous Market Research Pvt. Ltd.
Redding, California, Nov. 22, 2022 (GLOBE NEWSWIRE) -- According to a new market research report titled, ‘Point-of-Care Diagnostics Market by Application (Influenza, Pneumonia, COVID-19, TB, HAI,...
Sandoz announces further investment in key manufacturing facility in Austria, to support increased global demand for essential antibiotics
November 07, 2022 06:00 ET
|
Novartis Pharma AG
EUR 50m planned investment to support increased manufacturing capacity for finished dosage form penicillins, the leading class of antibiotics worldwideNew project brings total planned investment into...
Molecular Diagnostics Market Worth $25.59 Billion by 2029 - Exclusive Report by Meticulous Research®
November 02, 2022 10:42 ET
|
Meticulous Market Research Pvt. Ltd.
Redding, California, Nov. 02, 2022 (GLOBE NEWSWIRE) -- According to a new market research report, ‘Molecular Diagnostics Market by Product (Reagents & Kits, Systems, Software), Test Type (Lab,...
Pharmacogenomics Market Worth $13.16 Billion by 2029 - Exclusive Report by Meticulous Research®
October 19, 2022 06:17 ET
|
Meticulous Market Research Pvt. Ltd.
Redding, California, Oct. 19, 2022 (GLOBE NEWSWIRE) -- According to a new market research report, ‘Pharmacogenomics Market by Technology (PCR, Sequencing, Spectrometry, Electrophoresis),...
Evaxion welcomes Per Norlén as new CEO.
October 05, 2022 08:32 ET
|
Evaxion Biotech
COPENHAGEN, Denmark, Oct. 05, 2022 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage biotechnology company specializing in the development of...
Diagnostic Specialty Antibodies Market to Be Worth $39.99 Billion by 2029: Meticulous Research®
September 27, 2022 08:45 ET
|
Meticulous Market Research Pvt. Ltd.
Redding, California, Sept. 27, 2022 (GLOBE NEWSWIRE) -- Antibodies play a vital role in the detection of foreign molecules (antigens). Antibodies are rapidly generated as a response to infections...
Global Hand Sanitizer Market Projected to Gather $14,521.7 Million and Grow at 24.2% CAGR by 2027 Post Covid-19 Pandemic | Update by Research Dive
September 26, 2022 09:03 ET
|
Research Dive
New York, USA, Sept. 26, 2022 (GLOBE NEWSWIRE) -- According to the report published by Research Dive, the global hand sanitizer market is projected to gather a revenue of $14,521.7 million and grow...
Icosavax Reports Second Quarter 2022 Financial Results and Provides Corporate Update
August 15, 2022 16:05 ET
|
Icosavax, Inc.
– Announced positive topline interim Phase 1/1b results for VLP vaccine candidate IVX-121 against respiratory syncytial virus (RSV) - – Icosavax plans to file an IND and initiate a Phase 1 trial...
Immunocore announces dosing of first patient with ImmTAV® bispecific for HIV
July 11, 2022 07:00 ET
|
Immunocore Holdings Limited
PRESS RELEASE Immunocore announces dosing of first patient with ImmTAV® bispecific for HIV IMC-M113V, T cell receptor bispecific, targets an HIV Gag antigen Single Ascending Dose portion of Phase...